{"id":"https://openalex.org/W1894416004","doi":null,"title":"Eponemycin exerts its antitumor effect through the inhibition of proteasome function.","display_name":"Eponemycin exerts its antitumor effect through the inhibition of proteasome function.","publication_year":1999,"publication_date":"1999-06-15","ids":{"openalex":"https://openalex.org/W1894416004","mag":"1894416004","pmid":"https://pubmed.ncbi.nlm.nih.gov/10383134"},"language":"en","primary_location":{"id":"pmid:10383134","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10383134","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100599448","display_name":"Lin Meng","orcid":"https://orcid.org/0000-0003-3802-0296","observed_orcids":["https://orcid.org/0000-0003-3802-0296"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L Meng","raw_affiliation_strings":["Department of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, Connecticut 06520-8103, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, Connecticut 06520-8103, USA","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091357121","display_name":"Benjamin H. B. Kwok","orcid":"https://orcid.org/0000-0002-3668-7049","observed_orcids":["https://orcid.org/0000-0002-3668-7049"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B H Kwok","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102668269","display_name":"Ny Sin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N Sin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5016866989","display_name":"Craig M. Crews","orcid":"https://orcid.org/0000-0002-8456-2005","observed_orcids":["https://orcid.org/0000-0002-8456-2005"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C M Crews","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.9861,"has_fulltext":false,"cited_by_count":155,"citation_normalized_percentile":{"value":0.91459471,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"59","issue":"12","first_page":"2798","last_page":"801"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/proteasome-inhibition","display_name":"proteasome inhibition","score":0.9539999961853027},{"id":"https://openalex.org/keywords/20s-proteasome","display_name":"20S proteasome","score":0.9990000128746033},{"id":"https://openalex.org/keywords/lmp2","display_name":"LMP2","score":0.9599999785423279},{"id":"https://openalex.org/keywords/lmp7","display_name":"LMP7","score":1.0},{"id":"https://openalex.org/keywords/cyclin-degradation","display_name":"cyclin degradation","score":0.6460000276565552},{"id":"https://openalex.org/keywords/cell-cycle-regulation","display_name":"cell cycle regulation","score":0.7720000147819519},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.7639999985694885},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.7720000147819519},{"id":"https://openalex.org/keywords/natural-product-derivatives","display_name":"natural product derivatives","score":0.5789999961853027}],"concepts":[{"id":"https://openalex.org/C27740335","wikidata":"https://www.wikidata.org/wiki/Q14878333","display_name":"Proteasome","level":2,"score":0.9450244307518005},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.6321071982383728},{"id":"https://openalex.org/C107888121","wikidata":"https://www.wikidata.org/wiki/Q418432","display_name":"Anaphase-promoting complex","level":5,"score":0.4708808362483978},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.44411173462867737},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.4293043613433838},{"id":"https://openalex.org/C120089663","wikidata":"https://www.wikidata.org/wiki/Q59250999","display_name":"Cyclin","level":4,"score":0.42551687359809875},{"id":"https://openalex.org/C25602115","wikidata":"https://www.wikidata.org/wiki/Q407111","display_name":"Ubiquitin","level":3,"score":0.41763442754745483},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3870941996574402},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3356712758541107},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.33511173725128174},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3308422565460205},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.08632797002792358}],"mesh":[{"descriptor_ui":"D000577","descriptor_name":"Amides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000903","descriptor_name":"Antibiotics, Antineoplastic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002417","descriptor_name":"Cattle","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003546","descriptor_name":"Cysteine Endopeptidases","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D003546","descriptor_name":"Cysteine Endopeptidases","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D009097","descriptor_name":"Multienzyme Complexes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D009097","descriptor_name":"Multienzyme Complexes","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D012694","descriptor_name":"Serine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D012694","descriptor_name":"Serine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D046988","descriptor_name":"Proteasome Endopeptidase Complex","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:10383134","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10383134","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},{"id":"mag:1894416004","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10383134","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8560000061988831}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4403540867","display_name":"MOLECULAR ANALYSIS OF EPONEMYCIN BINDING PROTEINS","funder_award_id":"R01CA074967","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1565074159","https://openalex.org/W1594617739","https://openalex.org/W1968009051","https://openalex.org/W1970235416","https://openalex.org/W1973963032","https://openalex.org/W1980976120","https://openalex.org/W1990715120","https://openalex.org/W2001728435","https://openalex.org/W2039839254","https://openalex.org/W2042735601","https://openalex.org/W2057997371","https://openalex.org/W2060736209","https://openalex.org/W2062886087","https://openalex.org/W2066284211","https://openalex.org/W2083592950","https://openalex.org/W2091020556","https://openalex.org/W2101759139","https://openalex.org/W2120774330","https://openalex.org/W2130115789","https://openalex.org/W2131609927","https://openalex.org/W2151458137","https://openalex.org/W2173553938","https://openalex.org/W2949380422"],"related_works":["https://openalex.org/W2042556488","https://openalex.org/W1971676222","https://openalex.org/W2022778815","https://openalex.org/W2026771817","https://openalex.org/W2335082157","https://openalex.org/W2090401216","https://openalex.org/W628920831","https://openalex.org/W2094438078","https://openalex.org/W1992692251","https://openalex.org/W2067653691"],"abstract_inverted_index":{"Cell":[0],"cycle":[1],"progression":[2],"requires":[3],"the":[4,21,25,28,51,60,75,82,88,113,126],"proteasome-mediated":[5],"degradation":[6],"of":[7,24,30,50,68,87,128],"key":[8],"regulatory":[9],"proteins":[10],"such":[11],"as":[12,38,115],"cyclins,":[13],"cyclin-dependent":[14],"kinase":[15],"inhibitors,":[16],"and":[17,53,79,108,122],"anaphase-inhibitory":[18],"proteins.":[19],"Given":[20],"central":[22],"role":[23],"proteasome":[26,33,89,100,114],"in":[27],"destruction":[29],"these":[31],"proteins,":[32],"inhibition":[34,101],"has":[35],"been":[36],"proposed":[37],"a":[39,66,103,116],"possible":[40],"cancer":[41],"therapy.":[42],"We":[43],"report":[44],"here":[45],"that":[46],"dihydroeponemycin,":[47],"an":[48],"analogue":[49],"antitumor":[52,119],"antiangiogenic":[54],"natural":[55],"product":[56],"eponemycin,":[57],"selectively":[58],"targets":[59],"20S":[61],"proteasome.":[62],"Dihydroeponemycin":[63],"covalently":[64],"modifies":[65],"subset":[67],"catalytic":[69],"proteasomal":[70],"subunits,":[71],"binding":[72],"preferentially":[73],"to":[74],"IFN-gamma-inducible":[76],"subunits":[77],"LMP2":[78],"LMP7.":[80],"Moreover,":[81],"three":[83],"major":[84],"peptidolytic":[85],"activities":[86],"are":[90,123],"inhibited":[91],"by":[92],"dihydroeponemycin":[93],"at":[94],"different":[95],"rates.":[96],"In":[97],"addition,":[98],"dihydroeponemycin-mediated":[99],"induces":[102],"spindle-like":[104],"cellular":[105],"morphological":[106],"change":[107],"apoptosis.":[109],"These":[110],"results":[111],"validate":[112],"target":[117],"for":[118,125],"pharmacological":[120],"intervention":[121],"relevant":[124],"design":[127],"novel":[129],"chemotherapeutic":[130],"strategies.":[131]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":8}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}